Professional Acne Treatment Industry Analysis, Growth and Demand Forecast to 2030

Posted by Aryan on October 2nd, 2023

The professional acne treatment market will grow at a compound annual growth rate of 7.6% by the end of this decade to reach a value of USD 13,124.5 million by 2030.

This growth of the industry has a lot to do with the increasing occurrence of acne, rising disposable income in developing and developed countries, growing healthcare outlay, and growing count of research programs.

Inflammatory acne was the larger category in the past in the industry, on the basis of acne type. This has a lot to do with the instant need for effective treatment since it is usually painful.

North America was the leader of the industry owing to the increasing occurrence of acne, growing consciousness on newly advanced drugs, large drug pipeline, and high income per capita.

Download sample copy of this report: https://www.psmarketresearch.com/market-analysis/professional-acne-treatment-market/report-sample

Furthermore, the region is marked by the existence of protruding dermatology drug manufacturers, like Bausch Health Companies Inc., Johnson & Johnson, and Pfizer Inc., providing many classes of drugs to the regional population.

Many pharma companies are introducing new products, becoming a key trend in the industry. For example, in August 2020, Cassiopea SpA received the FDA approval for Winlevi, a cream designed for treating acne in patients of twelve years and older.

Furthermore, AnnJi Pharmaceutical Co. Ltd. engaged in the expansion of AJ101, a topical cream for treating acne vulgaris. The active element in AJ101 is a new androgen receptor degradation enhancer, effectively reduces activity level of the androgen receptor, arbitrated by the ubiquitin–proteasome system with the help of activation of the Nrf1 pathway.

Acne is perhaps the most common skin issue all over the world. And, because of the increasing number of acne treatments happening, it will have a positive impact on the demand for professional acne treatment in the years to come.